The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
232
Oral, during 24 weeks.
Oral, placebo for 12 weeks and pantogar for 12 weeks.
Oral, during only 12 weeks.
Caep Centro Avancado de Estudos E Pesquisas Ltda
Campinas, São Paulo, Brazil
Hair density
Time frame: 24 weeks
Incidence and severity of adverse events recorded during the study
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.